Clinical Study for the Investigation and Validation of a Therapy Procedure for the Adjustment of Risk Factors in Patients With Coronary Heart Disease by Means of Digital Therapy Control

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

October 31, 2026

Conditions
Coronary Artery DiseaseCardiovascular DiseasesCoronary Heart DiseaseIschemic Heart Disease
Interventions
DEVICE

CHD therapy through iATROS medical device

The intervention to be carried out in the treatment group is the use of the therapy control for the treatment of CHD played out via the iATROS medicine product. Patients will receive a suitable and medical device certified measuring device for recording vital parameters. The iATROS app is downloaded to the patient's smartphone and the app is activated by entering a code that identifies the user as a participant in the study. When using the app for the first time, the patient is guided through the first steps of using the app and asked to transfer his or her health data to the app. The therapy control by means of the medication product takes place over the entire duration of the study.

Trial Locations (1)

81377

RECRUITING

Klinikum der Ludwig-Maximilians-Universität München (Klinikum der Universität München), Medizinische Klinik und Poliklinik I, Munich

All Listed Sponsors
lead

iATROS GmbH

INDUSTRY